Charles V. Pollack

Idarucizumab for Dabigatran Reversal

Charles V. Pollack, Paul A. Reilly, John W. Eikelboom et al. · New England Journal of Medicine · 2015 · 1.5K citations

Medicine, Pharmacology, Pharmacotherapy +4

Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction

Sumeet Subherwal, Richard G. Bach, Anita Y. Chen et al. · Circulation · 2009 · 991 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Association Between Hospital Process Performance and Outcomes Among Patients With Acute Coronary Syndromes

Eric D. Peterson, Matthew T. Roe, Jyotsna Mulgund et al. · JAMA · 2006 · 674 citations

Nursing, Cardiology, Internal Medicine +17

Intravenous Platelet Blockade with Cangrelor during PCI

Deepak L. Bhatt, A. Michael Lincoff, C. Michael Gibson et al. · New England Journal of Medicine · 2009 · 643 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Platelet Inhibition with Cangrelor in Patients Undergoing PCI

Robert A. Harrington, Gregg W. Stone, Steven E. McNulty et al. · New England Journal of Medicine · 2009 · 618 citations · Full text

Medicine, Cardiology, Pharmacology +16